Literature DB >> 3557192

Urinary N-nitrosoproline excretion: a further evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions.

C N Hall, J S Kirkham, T C Northfield.   

Abstract

Measurement of N-nitroso compounds in gastric juice by different methods has given conflicting results. In order to resolve this controversy, we have assessed endogenous nitrosation by the independent N-nitrosoproline excretion test in subjects who had previously undergone gastric juice analysis by one of these methods. Ten Polya gastrectomy, 10 pernicious anaemia and nine matched control subjects were fed 380 mg of nitrate in beetroot juice and 500 mg proline. N-nitrosoproline (N-Pro) synthesised intragastrically from these precursors, and quantitatively excreted by the kidneys, was measured in 24 hour urine samples (collection checked by creatinine clearance). N-Pro excretion (mean +/- SEM) was reduced (p less than 0.01) in pernicious anaemia (1.1 +/- 0.8 ng/day) compared with matched control (18.0 +/- 7.2 ng/day), and also tended to be lower (NS) in polya gastrectomy (3.2 +/- 2.3 ng/day). Twenty four hour intragastric pH was monitored on a separate occasion in 23 of the 29 subjects; 13 were hypoacidic (pH greater than 4 greater than 50% of 24 hours) and 10 were acidic. N-Pro yields were reduced (p less than 0.01) in the hypoacidic group (0.9 +/- 0.6 ng/day) compared with the acidic group (17.9 +/- 6.6 ng/day), and N-Pro was negatively associated with mean intragastric pH (tau = -0.53, p = 0.001). We conclude that endogenous synthesis of this specific N-nitroso compound is favoured by low rather than high pH. These results are concordant with those previously reported in gastric juice from the same subjects and suggest that nitrosation is chemically rather than bacterially mediated, contrary to the nitrosamine hypothesis of gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3557192      PMCID: PMC1432965          DOI: 10.1136/gut.28.2.216

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Kinetics of nitrosation of the amino acids proline, hydroxyproline, and sarcosine.

Authors:  S S Mirvish; J Sams; T Y Fan; S R Tannenbaum
Journal:  J Natl Cancer Inst       Date:  1973-12       Impact factor: 13.506

2.  The effect of pH on dimethylnitrosamine formation in human gastric juice.

Authors:  R P Lane; M E Bailey
Journal:  Food Cosmet Toxicol       Date:  1973-10

3.  Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment.

Authors:  P I Reed; K Haines; P L Smith; C L Walters; F R House
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

4.  Nitrite and N-nitroso compounds in gastric juice.

Authors:  W S Ruddell; C L Walters
Journal:  Lancet       Date:  1980-05-31       Impact factor: 79.321

5.  Pathogenesis of gastric cancer in pernicious anaemia.

Authors:  W S Ruddell; E S Bone; M J Hill; C L Walters
Journal:  Lancet       Date:  1978-03-11       Impact factor: 79.321

6.  Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment.

Authors:  G J Milton-Thompson; N F Lightfoot; Z Ahmet; R H Hunt; J Barnard; P M Bavin; R W Brimblecombe; D W Darkin; P J Moore; N Viney
Journal:  Lancet       Date:  1982-05-15       Impact factor: 79.321

7.  Gastric juice N-nitrosamines in health and gastroduodenal disease.

Authors:  P I Reed; P L Smith; K Haines; F R House; C L Walters
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

8.  Nitrosamine formation in human saliva.

Authors:  S R Tannenbaum; M C Archer; J S Wishnok; W W Bishop
Journal:  J Natl Cancer Inst       Date:  1978-02       Impact factor: 13.506

9.  A model for gastric cancer epidemiology.

Authors:  P Correa; W Haenszel; C Cuello; S Tannenbaum; M Archer
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

10.  Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions.

Authors:  C N Hall; D Darkin; R Brimblecombe; A J Cook; J S Kirkham; T C Northfield
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

View more
  6 in total

Review 1.  Carcinoma of the gastric stump: risks and pathogenesis.

Authors:  T C Northfield; C N Hall
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

Review 2.  Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.

Authors:  M Deakin; J G Williams
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 3.  Effects of acid suppression on microbial flora of upper gut.

Authors:  N D Yeomans; R W Brimblecombe; J Elder; R V Heatley; J J Misiewicz; T C Northfield; A Pottage
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 4.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 5.  Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.

Authors:  W Creutzfeldt
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

6.  Use of a modified N-nitrosoproline test to show intragastric nitrosation in patients at risk of gastric cancer.

Authors:  P W Houghton; S Leach; R W Owen; N J McC Mortensen; M J Hill; R C Williamson
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.